Skin pigmentation secondary to minocycline therapy
- 1 November 1980
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 116 (11) , 1262-1265
- https://doi.org/10.1001/archderm.116.11.1262
Abstract
• Localized brown to blue-black discoloration of the skin occurred in three patients receiving long-term minocycline hydrochloride therapy. Abundant perivascular pigmented material was present at all levels of the dermis below the upper papillary portion. Histochemical studies demonstrated reactivity with the Prussian blue stain and the Fontana-Masson silver technique. The granules were brightly refractile by dark-field illumination. Ultrastructurally, there were membranebound dense intracellular inclusions differing from melanin and iron but identical to those known to occur in the thyroid glands of minocycline-primed laboratory animals. The abnormal pigment most likely represents a metabolic derivative of minocycline. (Arch Dermatol116:1262-1265, 1980)This publication has 4 references indexed in Scilit:
- Clofazimine in the treatment of pyoderma gangrenosumArchives of Dermatology, 1979
- Localized hemosiderosis as a sequela of acneArchives of Dermatology, 1978
- Skin pigmentation and chlorpromazineJAMA, 1965
- Hyperpigmentierungen vom Typus des Chloasmas nach Behandlung mit Hydantoin-PräparatenDermatology, 1964